Skip to main content
Erschienen in: American Journal of Clinical Dermatology 6/2013

01.12.2013 | Systematic Review

Diagnostic Performance of Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography in Patients with Merkel Cell Carcinoma: A Systematic Review and Meta-Analysis

verfasst von: Giorgio Treglia, Vahid Reza Dabbagh Kakhki, Luca Giovanella, Ramin Sadeghi

Erschienen in: American Journal of Clinical Dermatology | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract:

Background

Some studies reported the usefulness of fluorine-18-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) and PET/computed tomography (CT) in patients with Merkel cell carcinoma (MCC).

Objective

The aim of this study was to systematically review and meta-analyze published data about the diagnostic performance of 18F-FDG PET and PET/CT in patients with MCC.

Methods

A comprehensive literature search of studies published through June 2013 regarding 18F-FDG PET and PET/CT in patients with MCC was performed. All retrieved studies were reviewed and qualitatively analyzed. Pooled sensitivity, specificity, positive and negative likelihood ratio (LR+ and LR−) and diagnostic odds ratio (DOR) of 18F-FDG PET or PET/CT in patients with MCC on a per examination-based analysis were calculated. The area under the summary receiver operating characteristic (ROC) curve was calculated to measure the accuracy of 18F-FDG PET or PET/CT in these patients.

Results

Ten studies comprising 329 patients (549 scans) with MCC were included in the qualitative analysis (systematic review) and discussed. The quantitative analysis (meta-analysis) of six selected studies (including 92 patients with MCC) provided the following results on a per examination-based analysis: sensitivity was 90 % (95 % CI 80–96), specificity 98 % (95 % CI 90–100), LR+ 12 (95 % CI 4.3–33.0), LR− 0.15 (95 % CI 0.08–0.28), and DOR 86.8 (95 % CI 23–327). The area under the summary ROC curve was 0.96. No significant statistical heterogeneity between the studies was found.

Conclusions

In patients with MCC, 18F-FDG PET or PET/CT demonstrated high sensitivity and specificity, being accurate methods in this setting. Nevertheless, the literature focusing on the use of PET and PET/CT in MCC still remains limited. Prospective studies are needed to substantiate the high diagnostic accuracy of these methods in MCC.
Literatur
1.
Zurück zum Zitat Senchenkov A, Moran SL. Merkel cell carcinoma: diagnosis, management, and outcomes. Plast Reconstr Surg. 2013;131:771–778e.CrossRef Senchenkov A, Moran SL. Merkel cell carcinoma: diagnosis, management, and outcomes. Plast Reconstr Surg. 2013;131:771–778e.CrossRef
2.
Zurück zum Zitat Allen PJ, Bowne WB, Jaques DP, et al. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol. 2005;23:2300–9.PubMedCrossRef Allen PJ, Bowne WB, Jaques DP, et al. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol. 2005;23:2300–9.PubMedCrossRef
3.
Zurück zum Zitat Han SY, North JP, Canavan T, et al. Merkel cell carcinoma. Hematol Oncol Clin North Am. 2012;26:1351–74.PubMedCrossRef Han SY, North JP, Canavan T, et al. Merkel cell carcinoma. Hematol Oncol Clin North Am. 2012;26:1351–74.PubMedCrossRef
4.
Zurück zum Zitat Howle JR, Hughes TM, Gebski V, et al. Merkel cell carcinoma: an Australian perspective and the importance of addressing the regional lymph nodes in clinically node-negative patients. J Am Acad Dermatol. 2012;67:33–40.PubMedCrossRef Howle JR, Hughes TM, Gebski V, et al. Merkel cell carcinoma: an Australian perspective and the importance of addressing the regional lymph nodes in clinically node-negative patients. J Am Acad Dermatol. 2012;67:33–40.PubMedCrossRef
5.
Zurück zum Zitat Enzenhofer E, Ubl P, Czerny C, et al. Imaging in patients with merkel cell carcinoma. J Skin Cancer. 2013;2013:973123.PubMed Enzenhofer E, Ubl P, Czerny C, et al. Imaging in patients with merkel cell carcinoma. J Skin Cancer. 2013;2013:973123.PubMed
6.
Zurück zum Zitat Treglia G, Cason E, Fagioli G. Recent applications of nuclear medicine in diagnostics (first part). Ital J Med. 2010;4:84–91.CrossRef Treglia G, Cason E, Fagioli G. Recent applications of nuclear medicine in diagnostics (first part). Ital J Med. 2010;4:84–91.CrossRef
7.
Zurück zum Zitat Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62:e1–34.PubMedCrossRef Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62:e1–34.PubMedCrossRef
9.
Zurück zum Zitat Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.PubMedCrossRef Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.PubMedCrossRef
10.
Zurück zum Zitat Zamora J, Abraira V, Muriel A, et al. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol. 2006;6:31.PubMedCrossRef Zamora J, Abraira V, Muriel A, et al. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol. 2006;6:31.PubMedCrossRef
11.
Zurück zum Zitat Siva S, Byrne K, Seel M, et al. 18F-FDG PET provides high-impact and powerful prognostic stratification in the staging of merkel cell carcinoma: a 15-year institutional experience. J Nucl Med. 2013;. doi:10.2967/jnumed.112.116814.PubMed Siva S, Byrne K, Seel M, et al. 18F-FDG PET provides high-impact and powerful prognostic stratification in the staging of merkel cell carcinoma: a 15-year institutional experience. J Nucl Med. 2013;. doi:10.​2967/​jnumed.​112.​116814.PubMed
12.
Zurück zum Zitat Ibrahim SF, Ahronowitz I, McCalmont TH, et al. 18F-fluorodeoxyglucose positron emission tomography–computed tomography imaging in the management of merkel cell carcinoma: a single-institution retrospective study. Dermatol Surg. 2013;. doi:10.1111/dsu.12246. Ibrahim SF, Ahronowitz I, McCalmont TH, et al. 18F-fluorodeoxyglucose positron emission tomography–computed tomography imaging in the management of merkel cell carcinoma: a single-institution retrospective study. Dermatol Surg. 2013;. doi:10.​1111/​dsu.​12246.
13.
Zurück zum Zitat Hawryluk EB, O’Regan KN, Sheehy N, et al. Positron emission tomography/computed tomography imaging in Merkel cell carcinoma: a study of 270 scans in 97 patients at the Dana-Farber/Brigham and Women’s Cancer Center. J Am Acad Dermatol. 2013;68:592–9.PubMedCrossRef Hawryluk EB, O’Regan KN, Sheehy N, et al. Positron emission tomography/computed tomography imaging in Merkel cell carcinoma: a study of 270 scans in 97 patients at the Dana-Farber/Brigham and Women’s Cancer Center. J Am Acad Dermatol. 2013;68:592–9.PubMedCrossRef
14.
Zurück zum Zitat Colgan MB, Tarantola TI, Weaver AL, et al. The predictive value of imaging studies in evaluating regional lymph node involvement in Merkel cell carcinoma. J Am Acad Dermatol. 2012;67:1250–6.PubMedCrossRef Colgan MB, Tarantola TI, Weaver AL, et al. The predictive value of imaging studies in evaluating regional lymph node involvement in Merkel cell carcinoma. J Am Acad Dermatol. 2012;67:1250–6.PubMedCrossRef
15.
Zurück zum Zitat Lu Y, Fleming SE, Fields RC, et al. Comparison of 18F-FDG PET/CT and 111In pentetreotide scan for detection of Merkel cell carcinoma. Clin Nucl Med. 2012;37:759–62.PubMedCrossRef Lu Y, Fleming SE, Fields RC, et al. Comparison of 18F-FDG PET/CT and 111In pentetreotide scan for detection of Merkel cell carcinoma. Clin Nucl Med. 2012;37:759–62.PubMedCrossRef
16.
Zurück zum Zitat Maury G, Dereure O, Du-Thanh A, et al. Interest of (18)F-FDG PET–CT scanning for staging and management of merkel cell carcinoma: a retrospective study of 15 patients. J Eur Acad Dermatol Venereol. 2011;25:1420–7.PubMedCrossRef Maury G, Dereure O, Du-Thanh A, et al. Interest of (18)F-FDG PET–CT scanning for staging and management of merkel cell carcinoma: a retrospective study of 15 patients. J Eur Acad Dermatol Venereol. 2011;25:1420–7.PubMedCrossRef
17.
Zurück zum Zitat Concannon R, Larcos GS, Veness M. The impact of (18)F-FDG PET–CT scanning for staging and management of Merkel cell carcinoma: results from Westmead Hospital, Sydney, Australia. J Am Acad Dermatol. 2010;62:76–84.PubMedCrossRef Concannon R, Larcos GS, Veness M. The impact of (18)F-FDG PET–CT scanning for staging and management of Merkel cell carcinoma: results from Westmead Hospital, Sydney, Australia. J Am Acad Dermatol. 2010;62:76–84.PubMedCrossRef
18.
Zurück zum Zitat Peloschek P, Novotny C, Mueller-Mang C, et al. Diagnostic imaging in Merkel cell carcinoma: lessons to learn from 16 cases with correlation of sonography, CT, MRI and PET. Eur J Radiol. 2010;73:317–23.PubMedCrossRef Peloschek P, Novotny C, Mueller-Mang C, et al. Diagnostic imaging in Merkel cell carcinoma: lessons to learn from 16 cases with correlation of sonography, CT, MRI and PET. Eur J Radiol. 2010;73:317–23.PubMedCrossRef
19.
Zurück zum Zitat Belhocine T, Pierard GE, Frühling J, et al. Clinical added-value of 18FDG PET in neuroendocrine-merkel cell carcinoma. Oncol Rep. 2006;16:347–52.PubMed Belhocine T, Pierard GE, Frühling J, et al. Clinical added-value of 18FDG PET in neuroendocrine-merkel cell carcinoma. Oncol Rep. 2006;16:347–52.PubMed
20.
Zurück zum Zitat Iagaru A, Quon A, McDougall IR, et al. Merkel cell carcinoma: is there a role for 2-deoxy-2-[f-18]fluoro-d-glucose-positron emission tomography/computed tomography? Mol Imaging Biol. 2006;8:212–7.PubMedCrossRef Iagaru A, Quon A, McDougall IR, et al. Merkel cell carcinoma: is there a role for 2-deoxy-2-[f-18]fluoro-d-glucose-positron emission tomography/computed tomography? Mol Imaging Biol. 2006;8:212–7.PubMedCrossRef
21.
Zurück zum Zitat Mirk P, Treglia G, Salsano M, et al. Comparison between F-fluorodeoxyglucose positron emission tomography and sentinel lymph node biopsy for regional lymph nodal staging in patients with melanoma: a review of the literature. Radiol Res Pract. 2011;2011:912504.PubMed Mirk P, Treglia G, Salsano M, et al. Comparison between F-fluorodeoxyglucose positron emission tomography and sentinel lymph node biopsy for regional lymph nodal staging in patients with melanoma: a review of the literature. Radiol Res Pract. 2011;2011:912504.PubMed
22.
Zurück zum Zitat Treglia G, Castaldi P, Rufini V, et al. Diagnostic performance of Gallium-68 somatostatin receptor PET and PET/CT in patients with thoracic and gastroenteropancreatic neuroendocrine tumours: a meta-analysis. Endocrine. 2012;42:80–7.PubMedCrossRef Treglia G, Castaldi P, Rufini V, et al. Diagnostic performance of Gallium-68 somatostatin receptor PET and PET/CT in patients with thoracic and gastroenteropancreatic neuroendocrine tumours: a meta-analysis. Endocrine. 2012;42:80–7.PubMedCrossRef
23.
Zurück zum Zitat Treglia G, Sadeghi R. Meta-analyses and systematic reviews on PET and PET/CT in oncology: the state of the art. Clin Transl Imaging. 2013;1:73–5.CrossRef Treglia G, Sadeghi R. Meta-analyses and systematic reviews on PET and PET/CT in oncology: the state of the art. Clin Transl Imaging. 2013;1:73–5.CrossRef
25.
Zurück zum Zitat Ratib O. PET/MRI: a new era in multimodality molecular imaging. Clin Transl Imaging. 2013;1:5–10.CrossRef Ratib O. PET/MRI: a new era in multimodality molecular imaging. Clin Transl Imaging. 2013;1:5–10.CrossRef
26.
Zurück zum Zitat Pace L, Nicolai E, Aiello M, et al. Whole-body PET/MRI in oncology: current status and clinical applications. Clin Transl Imaging. 2013;1:31–44.CrossRef Pace L, Nicolai E, Aiello M, et al. Whole-body PET/MRI in oncology: current status and clinical applications. Clin Transl Imaging. 2013;1:31–44.CrossRef
Metadaten
Titel
Diagnostic Performance of Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography in Patients with Merkel Cell Carcinoma: A Systematic Review and Meta-Analysis
verfasst von
Giorgio Treglia
Vahid Reza Dabbagh Kakhki
Luca Giovanella
Ramin Sadeghi
Publikationsdatum
01.12.2013
Verlag
Springer International Publishing
Erschienen in
American Journal of Clinical Dermatology / Ausgabe 6/2013
Print ISSN: 1175-0561
Elektronische ISSN: 1179-1888
DOI
https://doi.org/10.1007/s40257-013-0040-x

Weitere Artikel der Ausgabe 6/2013

American Journal of Clinical Dermatology 6/2013 Zur Ausgabe

Acknowledgement to Referees

Acknowledgement

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärztinnen und Psychotherapeuten.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders scheint das auf weibliche Kranke zuzutreffen, wie eine Studie zeigt.

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.